A recent study examined the current economic burden attributable to vaccine-preventable diseases among U.S. adults.
Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
Teen girls living in high-poverty and in majority Hispanic communities had the highest rates of having received at least 1 dose of the HPV vaccine compared with those in low-poverty communities and in communities of other racial or ethnic compositions.
Many pediatricians and primary care physicians reported communicating about HPV vaccination with parents in ways that likely discourage them from having their children vaccinated.
Physicians failing to recommend it or adequately explain its benefits to parents could be a factor.
A sizable minority of doctors does not strongly endorse HPV vaccination nor deliver timely recommendations.
Immunization protects against sexually transmitted disease and certain cancers, health experts say, but only two U.S. states mandate vaccination.
Reports on outbreaks of measles, pertussis in past year may have shifted opinions on vaccination.
Researchers note that CDC recommends vaccination at age 11 or 12, but only half of girls receiving the vaccination get it at the proper age.
An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.
Vaccine is effective even among older adults who subsequently undergo chemotherapy.
The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a recent study.
The HPV vaccine protects against cancers of the cervix, throat, rectum, and penis, but too few are receiving it.
Combination vaccine significantly improves overall survival in pancreatic cancer, compared with single-component vaccine.
This fact sheet examines the role of vaccines for the prevention and treatment of cancer, including current areas of research.
Patients with recurrent GBM treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine.
Vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma, according to a recently published study.
Vaccines and monoclonal antibodies are promising new treatments for patients with follicular lymphoma.
A new vaccine, derived from the patient's tumor cells, is designed to jumpstart the patient's immune system to attack and kill cancer cells.
A newly reported clinical trial used a vaccine that stimulated dendritic cells to treat newly diagnosed advanced melanoma.
HPV vaccination is widely offered but underused; many doctors continue to offer annual Pap smears.
Attacking glioblastoma brain tumor cells with a modified poliovirus is showing encouraging early results in an ongoing study.
In vaccines that stimulate an immune system assult, T cells aimed at tumors instead find the vaccination site a more inviting target.
Therapeutic vaccines for mucosal cancers may work best when administered directly at the site of those tumors rather than elsewhere.
What vaccines are appropriate or not appropriate for cancer patients?
In 2010, 32 percent had received three doses of vaccine; incidence of some HPV-linked cancers up.
Early results of a trial to treat leukemia with WT1 DNA vaccine have shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.
A therapeutic vaccine for women who are already harboring human papillomavirus (HPV) appeared to fight cervical cancer in a small, phase 1 study.
What are the recommendations for administering the human papillomavirus vaccine?
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|